论文部分内容阅读
据Ｍａｎｕ Ｃｈｅｍ（２０００ ７）报道 ,露华浓（Ｒｅｖｌｏｎ）日前与美国一家生物制药公司Ｓｅｎｔｋ签定合作协议 ,Ｒｅｖｌｏｎ将应用Ｓｅｎｅｔｅｋ先进的Ｋｉｎｅｔｉｎ技术开发护肤品和化妆品。Ｒｅｖｌｏｎ将有权限制部分亚洲地区的代理在全球范围内运用此项技术。
Manu Chem (2000) reported that Revlon has signed a cooperation agreement with Sentk, a biopharmaceutical company in the United States. Revlon will use Senetek’s advanced Kinetin technology to develop skin care products and cosmetics. Revlon will have the right to restrict the use of this technology by agents in some Asian countries worldwide.